FSD Pharma Inc.
HUGE · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $2,552 | $4,358 | $4,010 | $4,107 |
| Gross Profit | -$2,552 | -$4,358 | -$4,010 | -$4,107 |
| % Margin | – | – | – | – |
| R&D Expenses | $3,930 | $6,911 | $6,328 | $7,833 |
| G&A Expenses | $11,968 | $15,981 | $23,370 | $18,110 |
| SG&A Expenses | $13,447 | $15,981 | $23,370 | $18,110 |
| Sales & Mktg Exp. | $1,479 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $4,537 | $4,046 | $4,658 |
| Operating Expenses | $17,377 | $27,430 | $33,744 | $30,601 |
| Operating Income | -$19,929 | -$27,430 | -$33,744 | -$30,691 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $1,364 | $726 | -$194 | $2,239 |
| Pre-Tax Income | -$18,565 | -$26,704 | -$33,938 | -$28,452 |
| Tax Expense | $0 | -$3,382 | $1,468 | $4,267 |
| Net Income | -$18,565 | -$23,322 | -$35,406 | -$32,719 |
| % Margin | – | – | – | – |
| EPS | -0.47 | -0.6 | -1.01 | -2.72 |
| % Growth | 21.7% | 40.6% | 62.9% | – |
| EPS Diluted | -0.47 | -0.6 | -1.01 | -2.72 |
| Weighted Avg Shares Out | 39,588 | 38,732 | 34,945 | 12,044 |
| Weighted Avg Shares Out Dil | 39,589 | 38,732 | 34,945 | 12,044 |
| Supplemental Information | – | – | – | – |
| Interest Income | $801 | $368 | $1 | $4 |
| Interest Expense | $0 | $49 | $69 | $236 |
| Depreciation & Amortization | $2,552 | $4,535 | $4,046 | $3,900 |
| EBITDA | -$16,012 | -$22,120 | -$29,823 | -$24,316 |
| % Margin | – | – | – | – |